FDA clears Synchron's brain-computer interface device for human trials
Synchron, a company that develops implantable brain-computer interfaces (BCIs), has received permission from the U.S. Food and Drug Administration (FDA) to conduct clinical trials with human patients putting the company ahead of competitors like Elon Musk’s Neuralink. The company plans to start its early feasibility study of its...